Drug Shortage Report for TEVA-CLINDAMYCIN
Report ID | 218960 |
Drug Identification Number | 02241710 |
Brand name | TEVA-CLINDAMYCIN |
Common or Proper name | CLINDAMYCIN 300MG CAPS |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | CLINDAMYCIN |
Strength(s) | 300MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | J01FF |
ATC description | MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2024-02-07 |
Estimated end date | 2024-04-20 |
Actual end date | 2024-04-03 |
Shortage status | Resolved |
Updated date | 2024-04-05 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v16 | 2024-04-05 | French | Compare |
v15 | 2024-04-05 | English | Compare |
v14 | 2024-03-28 | French | Compare |
v13 | 2024-03-28 | English | Compare |
v12 | 2024-03-14 | French | Compare |
v11 | 2024-03-14 | English | Compare |
v10 | 2024-03-07 | French | Compare |
v9 | 2024-03-07 | English | Compare |
v8 | 2024-02-29 | French | Compare |
v7 | 2024-02-29 | English | Compare |
v6 | 2024-02-22 | French | Compare |
v5 | 2024-02-22 | English | Compare |
v4 | 2024-02-15 | French | Compare |
v3 | 2024-02-15 | English | Compare |
v2 | 2024-02-08 | French | Compare |
v1 | 2024-02-08 | English | Compare |
Showing 1 to 16 of 16